BTG3 and interstitial lung disease: In 2011, guidelines from the American Thoracic Society/European Respiratory Society/Japanese Respiratory Society and Latin American Thoracic Association highlight ANA, anti-CCP, and RF as necessary autoantibodies to test for in all potential ILD patients (24).